Showing results (2081-2090 of 2,107) with videos related to

Sort By:
Pageof 211
CNS Drugs|May 31, 2023
Pharmacological Management of Borderline Personality Disorder and Common ComorbiditiesJuan C Pascual, Laia Arias, Joaquim Soler
CNS Drugs|March 3, 2026
Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy TherapyWolfgang Löscher, Chris Rundfeldt, Eugen Trinka, et al.
CNS Drugs|February 19, 2026
Ameliorating Seizures in Dravet Syndrome: A Review of Newly Approved and Investigational Drugs, RNA and Gene-Based TherapiesSimona Balestrini, Ingrid E Scheffer
CNS Drugs|November 9, 2024
TICA-CLOP STUDY: Ticagrelor Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke, a Randomized Controlled Multi-Center TrialSherihan Rezk Ahmed, Nevine El Nahas, Mohamed Fouad Elsayed Khalil, et al.
CNS Drugs|May 21, 2026
The Evolving Pharmacological Landscape for Paediatric and Adult ADHDGuilherme Fusetto Veronesi, Fabio Tarantino, Daniele Pirolo, et al.
CNS Drugs|May 16, 2026
Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic ReviewOmer A Syed, Valentyn Sobolenko, Sean M Nestor, et al.
CNS Drugs|February 21, 2026
TRPV1 Receptor Modulators: Emerging Therapies for Neuropathic, Osteoarthritic, and Perioperative PainEdward H Tsai, Tong J Gan
CNS Drugs|January 22, 2023
Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor ModulationJules S Mitchell, Daniel F Hermens, Maxwell R Bennett, et al.
CNS Drugs|July 28, 2011
Vitamin D, cognitive dysfunction and dementia in older adultsAndy P Dickens, Iain A Lang, Kenneth M Langa, et al.
CNS Drugs|July 20, 2001
Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatmentF Brambilla
Pageof 211